Table 1 Baseline characteristics of patients with invasive candidiasis (IC)
From: Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study
Characteristics | Yeast infection, n = 22 |
|---|---|
Age (years), median (IQR) | 66 (53.7–74.2) |
Male sex, n (%) | 16 (72.7) |
Comorbidities, n (%) | 21 (95.4) |
Chronic renal failure, n (%) | 3 (13.6) |
Diabetes mellitus, n (%) | 7 (31.8) |
Solid tumor, n (%) | 7 (31.8) |
Steroid therapy, n (%) | 0 (0) |
Parenteral nutrition, n (%) | 14 (63.6) |
Mechanical ventilation, n (%) | 20 (90.9) |
Urinary catheter, n (%) | 22 (100) |
Central venous catheter (CVC), n (%) | 22 (100) |
CVC removed, n (%) | 22 (100) |
Yeast positivity in removed CVC, n (%) | 2 (9.1) |
Previous hospitalization, n (%) | 16 (72.7) |
Pre-IC diagnosis LOS (days), median (IQR) | 20 (5–37.5) |
LOS >7 days, n (%) | 15 (68.2) |
Admission typology | – |
Surgical pathology, n (%) | 20 (90.9) |
Medical pathology, n (%) | 2 (9.1) |
Trauma, n (%) | 0 (0) |
Abdominal surgery, n (%) | 14 (63.6) |
SOFA scorea on IC diagnosis, median (IQR) | 5 (3–6.2) |
Empirical therapy duration (days), median (IQR) | 10 (5–16.5) |
Previous antibiotic therapy, n (%) | 21 (95.4) |
Concomitant bacterial infection, n (%) | 20 (90.9) |
Concomitant bacteremia, n (%) | 9 (40.9) |
Fungemia, n (%) | 9 (40.9) |
Fungemia duration (days), median (IQR) | 7 (9.5–14.5) |
Previous fungal invasive infection, n (%) | 2 (9.1) |
C. albicans species, n (%) | 13 (59.1) |
Fungal multifocal colonization, n (%) | 8 (36.4) |
Colonization and infection species coincidence, n (%) | 6 (75) |
Mortality (global), n (%) | 3 (13.6) |
Early mortality (≤7 days), n (%) | 2 (9.1) |
Late mortality (>7 days), n (%) | 1 (4.5) |
Mortality in presence of fungemia, n (%) | 3 (33.3) |
Mortality in absence of fungemia, n (%) | 0 (0) |